Skip to main content
Top
Published in: Oral and Maxillofacial Surgery 2/2020

01-06-2020 | Bisphosphonate | Review Article

Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis

Authors: Gustavo Antonio Correa Momesso, Cleidiel Aparecido Araújo Lemos, Joel Ferreira Santiago-Júnior, Leonardo Perez Faverani, Eduardo Piza Pellizzer

Published in: Oral and Maxillofacial Surgery | Issue 2/2020

Login to get access

Abstract

Purpose

The aim of this study was to perform a systematic review and meta-analysis to evaluate the efficacy of laser therapy on medication-related osteonecrosis of the jaw (MRONJ) treatment.

Methods

This study followed PRISMA standards, and an electronic search was performed on the PubMed/MEDLINE, Scopus, and Cochrane databases. Eighty-nine articles were found. After reading the manuscripts, 15 articles remained for the review. Three of them were selected for meta-analysis.

Results

Female gender was predominant (72.5%), and mean age was 66.5 years. Follow-up varied between 3 and 80 months, and the most used bisphosphonate was zoledronic acid (71.6%). Stage II of MRONJ was the most prevalent (68.9%), and the mandible was the most affected site (64.5%). Qualitative data showed that treatment with laser surgery (Er:YAG) was most effective regarding complete healing of the lesion (90%) compared with other treatments. Meta-analysis data showed that low-level laser therapy (LLLT) was more effective than medical treatment (P = 0.006), and surgical treatment was more effective than LLLT (P = 0.008).

Conclusion

Laser surgery was significantly superior to LLLT (p < 0.00001). Therefore, laser surgical therapy seems to be a great management strategy for MRONJ treatment from stage II. LLLT was shown to improve conservative management in earlier MRONJ stages.
Literature
2.
go back to reference Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117–1124CrossRef Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117–1124CrossRef
3.
go back to reference Ruggiero SL, Drew SJ (2007) Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 86(11):1013–1021CrossRef Ruggiero SL, Drew SJ (2007) Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 86(11):1013–1021CrossRef
4.
go back to reference Ruggiero SL (2007) Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Cases Miner Bone Metab 4(1):37–42PubMedPubMedCentral Ruggiero SL (2007) Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ). Clin Cases Miner Bone Metab 4(1):37–42PubMedPubMedCentral
5.
go back to reference Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67(5):2–12CrossRef Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update. J Oral Maxillofac Surg 67(5):2–12CrossRef
6.
go back to reference Ruggiero SL (2013) An office-based approach to the diagnosis and management of osteonecrosis. Atlas Oral Maxillofac Surg Clin North Am 21(2):167–173CrossRef Ruggiero SL (2013) An office-based approach to the diagnosis and management of osteonecrosis. Atlas Oral Maxillofac Surg Clin North Am 21(2):167–173CrossRef
7.
go back to reference Mester E, Spiry T, Szende B, Tota JG (1971) Effect of laser rays on wound healing. Am J Surg 122(4):532–535CrossRef Mester E, Spiry T, Szende B, Tota JG (1971) Effect of laser rays on wound healing. Am J Surg 122(4):532–535CrossRef
9.
go back to reference Gál P, Mokrý M, Vidinský B, Kilík R, Depta F, Harakalová M, Longauer F, Mozes S, Sabo J (2009) Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and corticosteroid-treated rats. Lasers Med Sci 24(4):539–547. https://doi.org/10.1007/s10103-008-0604-9 CrossRefPubMed Gál P, Mokrý M, Vidinský B, Kilík R, Depta F, Harakalová M, Longauer F, Mozes S, Sabo J (2009) Effect of equal daily doses achieved by different power densities of low-level laser therapy at 635 nm on open skin wound healing in normal and corticosteroid-treated rats. Lasers Med Sci 24(4):539–547. https://​doi.​org/​10.​1007/​s10103-008-0604-9 CrossRefPubMed
13.
go back to reference Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, Pinheiro LH, Azevedo R, D'Aiuto de Matos V, Rodrigues PC, Small IA, Zangaro RA, Ferreira CG (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109(5):2250–2255. https://doi.org/10.1182/blood-2006-07-035022 CrossRefPubMed Antunes HS, de Azevedo AM, da Silva Bouzas LF, Adão CA, Pinheiro CT, Mayhe R, Pinheiro LH, Azevedo R, D'Aiuto de Matos V, Rodrigues PC, Small IA, Zangaro RA, Ferreira CG (2007) Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial. Blood 109(5):2250–2255. https://​doi.​org/​10.​1182/​blood-2006-07-035022 CrossRefPubMed
15.
go back to reference Hale GM, Querry MR (1973) Optical constants of water in the 200-nm to 200-microm wavelength region. Appl Opt 12(3):555–563CrossRef Hale GM, Querry MR (1973) Optical constants of water in the 200-nm to 200-microm wavelength region. Appl Opt 12(3):555–563CrossRef
19.
go back to reference Nelson JS, Orenstein A, Liaw LH, Berns MW (1989) Mid-infrared erbium: YAG laser ablation of bone: the effect of laser osteotomy on bone healing. Lasers Surg Med 9(4):362–374CrossRef Nelson JS, Orenstein A, Liaw LH, Berns MW (1989) Mid-infrared erbium: YAG laser ablation of bone: the effect of laser osteotomy on bone healing. Lasers Surg Med 9(4):362–374CrossRef
21.
go back to reference Coleman K, Norris S, Weston A, Grimmer-Sommers K, Hillier S, Merlin T (2015) NHMRC additional levels of evidence and grades for recommendations for developers of guidelines Coleman K, Norris S, Weston A, Grimmer-Sommers K, Hillier S, Merlin T (2015) NHMRC additional levels of evidence and grades for recommendations for developers of guidelines
34.
go back to reference Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30(1):5–13. https://doi.org/10.1089/pho.2010.2955 CrossRefPubMed Vescovi P, Manfredi M, Merigo E, Guidotti R, Meleti M, Pedrazzi G, Fornaini C, Bonanini M, Ferri T, Nammour S (2012) Early surgical laser-assisted management of bisphosphonate-related osteonecrosis of the jaws (BRONJ): a retrospective analysis of 101 treated sites with long-term follow-up. Photomed Laser Surg 30(1):5–13. https://​doi.​org/​10.​1089/​pho.​2010.​2955 CrossRefPubMed
39.
go back to reference Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123(11):1060–1064CrossRef Fedele S, Porter SR, D'Aiuto F, Aljohani S, Vescovi P, Manfredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123(11):1060–1064CrossRef
40.
go back to reference Ruggiero SL (2013) Emerging concepts in the management and treatment of osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am 25(1):11–20CrossRef Ruggiero SL (2013) Emerging concepts in the management and treatment of osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am 25(1):11–20CrossRef
41.
go back to reference Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg 70(7):1573–1583. https://doi.org/10.1016/j.joms.2012.04.001 CrossRefPubMed Freiberger JJ, Padilla-Burgos R, McGraw T, Suliman HB, Kraft KH, Stolp BW, Moon RE, Piantadosi CA (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofac Surg 70(7):1573–1583. https://​doi.​org/​10.​1016/​j.​joms.​2012.​04.​001 CrossRefPubMed
42.
go back to reference Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534CrossRef Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534CrossRef
46.
go back to reference Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32(10):2022–2029. https://doi.org/10.1002/jbmr.3191 CrossRefPubMed Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32(10):2022–2029. https://​doi.​org/​10.​1002/​jbmr.​3191 CrossRefPubMed
47.
go back to reference Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410CrossRef Marx RE, Cillo JE, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397–2410CrossRef
54.
Metadata
Title
Laser surgery in management of medication-related osteonecrosis of the jaws: a meta-analysis
Authors
Gustavo Antonio Correa Momesso
Cleidiel Aparecido Araújo Lemos
Joel Ferreira Santiago-Júnior
Leonardo Perez Faverani
Eduardo Piza Pellizzer
Publication date
01-06-2020
Publisher
Springer Berlin Heidelberg
Published in
Oral and Maxillofacial Surgery / Issue 2/2020
Print ISSN: 1865-1550
Electronic ISSN: 1865-1569
DOI
https://doi.org/10.1007/s10006-020-00831-0

Other articles of this Issue 2/2020

Oral and Maxillofacial Surgery 2/2020 Go to the issue